Remaining RLDs from pilot study- retention sample? [Regulatives / Guidelines]

posted by dshah  – India, 2023-10-03 19:27 (397 d 11:35 ago) – Posting: # 23735
Views: 1,876

Dear QA and RK!


❝ What if sponsor sent 1 bottle containing 56 tabs. of RLD to CRO for pilot study from which only 12 tabs. were utilized. Can rest of the tablets be used for pivotal study from the same opened bottle of RLD? Of course storage conditions were maintained in pharmacy of CRO.


Mostly you would not be able to use for below reasons.
- Does the remaining quantity is sufficient for testing or will you have sufficient retention samples? Generally the RLD samples are directly shipped to CRO and thus sponsor's may not have sufficient quantity of retention samples.

Regards,
Divyen Shah

Complete thread:

UA Flag
Activity
 Admin contact
23,280 posts in 4,889 threads, 1,655 registered users;
71 visitors (0 registered, 71 guests [including 10 identified bots]).
Forum time: 06:02 CET (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5